109th Congress preview
Executive Summary
Senate HELP Chair Mike Enzi's (R-Wyo.) health agenda for the 109th Congress includes a focus on drug safety, approvals, postmarket surveillance and clinical trial registries. On the House side, Energy & Commerce will resume oversight investigations of flu vaccine production, drug safety issues, Medicaid reimbursement and the NIH ethics program. Key staffers will discuss details during a Jan. 19 Drug & Device Dialogue web-based audio conference. For further information, or to register, go to 1www.drugdevicedialogue.com or call F-D-C Reports at 800-332-2181...
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.